In vitro suppression of latent HIV-1 activation by vitamin E : potential clinical implicationsHEREDIA, Alonso; DAVIS, Charles; AMOROSO, Anthony et al.AIDS (London). 2005, Vol 19, Num 8, pp 836-837, issn 0269-9370, 2 p.Article

CCR5 density levels on primary CD4 T cells impact the replication and enfuvirtide susceptibility of R5 HIV-1HEREDIA, Alonso; GILLIAM, Bruce; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 10, pp 1317-1322, issn 0269-9370, 6 p.Article

Rapamycin reduces CCR5 mRNA levels in macaques : potential applications in HIV-1 prevention and treatmentGILLIAM, Bruce L; HEREDIA, Alonso; DEVICO, Anthony et al.AIDS (London). 2007, Vol 21, Num 15, pp 2108-2110, issn 0269-9370, 3 p.Article

Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replicationHEREDIA, Alonso; DAVIS, Charles; BAMBA, Douty et al.AIDS (London). 2005, Vol 19, Num 18, pp 2087-2095, issn 0269-9370, 9 p.Article

Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitroHEREDIA, Alonso; GILLIAM, Bruce; LATINOVIC, Olga et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 7, pp 2489-2496, issn 0066-4804, 8 p.Article